Microbiota-mitochondria axis in neurodegenerative disorders and retinal dysfunction: mechanisms and emerging therapeutic opportunities
Puneet K. Samaiya, Akshat Agrawal, Shrija Kesharwani, Rini Sathe, Santosh Kumar Prajapati, Shreyasi Majumdar · 2026
Read Microbiota-mitochondria axis in neurodegenerative disorders and retinal dysfunction: mechanisms and emerging therapeutic opportunities by Puneet K. Samaiya, Akshat Agrawal, Shrija Kesharwani, Rini Sathe, Santosh Kumar Prajapati, Shreyasi Majumdar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575618.txt.
Description
Puneet Samaiya and five co-authors review the two-way conversation between gut microbes and mitochondria, the cell's energy producers, as a driver of brain and eye disease. Their review came out in 2026. When gut communities fall out of balance, mitochondria suffer through several routes at once.
Disturbed microbes make fewer helpful fatty acids, the gut wall leaks, and bacterial toxins raise inflammation and oxidative stress. Those hits are linked to Alzheimer's and Parkinson's diseases and to several retinal diseases, from macular degeneration to diabetic eye damage. Diet, heavy antibiotic use, and excess blue light may worsen the imbalance. Candidate treatments include next-generation probiotics, dietary change, and mitochondria-targeted antioxidants. The authors caution that most treatment evidence is still preclinical.
Catalog record
| CREATOR | Puneet K. Samaiya, Akshat Agrawal, Shrija Kesharwani, Rini Sathe, Santosh Kumar Prajapati, Shreyasi Majumdar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |